User profiles for Thomas F. Gajewski
Thomas F GajewskiProfessor, University of Chicago Verified email at medicine.bsd.uchicago.edu Cited by 70033 |
The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients
Anti–PD-1–based immunotherapy has had a major impact on cancer treatment but has only
benefited a subset of patients. Among the variables that could contribute to interpatient …
benefited a subset of patients. Among the variables that could contribute to interpatient …
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy
T cell infiltration of solid tumors is associated with favorable patient outcomes, yet the mechanisms
underlying variable immune responses between individuals are not well understood. …
underlying variable immune responses between individuals are not well understood. …
[PDF][PDF] STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors
Spontaneous T cell responses against tumors occur frequently and have prognostic value
in patients. The mechanism of innate immune sensing of immunogenic tumors leading to …
in patients. The mechanism of innate immune sensing of immunogenic tumors leading to …
[PDF][PDF] Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity
…, JJ Leong, K Metchette, TW Dubensky, TF Gajewski - Cell reports, 2015 - cell.com
Spontaneous tumor-initiated T cell priming is dependent on IFN-β production by tumor-resident
dendritic cells. On the basis of recent observations indicating that IFN-β expression was …
dendritic cells. On the basis of recent observations indicating that IFN-β expression was …
Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cells
… Murphy, Thomas F. Gajewski; Host type I IFN signals are required for antitumor CD8 + T cell
responses through CD8α + dendritic cells. J Exp Med 26 September 2011; 208 (10): 2005–…
responses through CD8α + dendritic cells. J Exp Med 26 September 2011; 208 (10): 2005–…
Innate and adaptive immune cells in the tumor microenvironment
TF Gajewski, H Schreiber, YX Fu - Nature immunology, 2013 - nature.com
Most tumor cells express antigens that can mediate recognition by host CD8 + T cells.
Cancers that are detected clinically must have evaded antitumor immune responses to grow …
Cancers that are detected clinically must have evaded antitumor immune responses to grow …
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
Melanoma treatment is being revolutionized by the development of effective immunotherapeutic
approaches 1 , 2 . These strategies include blockade of immune-inhibitory receptors on …
approaches 1 , 2 . These strategies include blockade of immune-inhibitory receptors on …
[PDF][PDF] Tumor-residing Batf3 dendritic cells are required for effector T cell trafficking and adoptive T cell therapy
… Further information and requests for resources and reagents should be directed to and
will be fulfilled by the Lead Contact, Thomas F. Gajewski (tgajewsk@medicine.bsd.uchicago.edu)…
will be fulfilled by the Lead Contact, Thomas F. Gajewski (tgajewsk@medicine.bsd.uchicago.edu)…
Anti-proliferative effect of IFN-gamma in immune regulation. I. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones.
TF Gajewski, FW Fitch - Journal of immunology (Baltimore, Md …, 1988 - journals.aai.org
A biphasic dose-response curve was observed when the IL-1-dependent HTL clone D10
was exposed to IL-1 plus supernatants from some activated T cell clones but not others. The …
was exposed to IL-1 plus supernatants from some activated T cell clones but not others. The …
The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies
The fine line between human health and disease can be driven by the interplay between
host and microbial factors. This “metagenome” regulates cancer initiation, progression, and …
host and microbial factors. This “metagenome” regulates cancer initiation, progression, and …